Haider Ackermann is a Colombian-born French fashion designer. He is the Creative Director of Canada Goose and the newly appointed Creative Director of Tom Ford. Adopted as a nine month old child by French-Alsatian parents, Haider's family traveled widely with his map-maker father, living in Algeria, Ethiopia and Iran, and eventually settling in the Netherlands when he was twelve years old. This blend of cultures that shaped him can be seen in his work, contrasting and resourcing dress-codes which incorporate flowing draped fabrics with more formal cuts. Haider Ackermann is much revered by his peers in the design industry; among many prestigious collaborations, he was also a guest designer for the Jean Paul Gaultier couture. He is sought after for special, red carpet creations by major stars including Timothée Chalamet and Tilda Swinton. On the day of his highly awaited first runway show for Tom Ford, we share a special episode of Fashion Neurosis where Haider Ackermann and Bella Freud discuss friendships and flirtations within the fashion industry, the unexpected joys of camping, and the significance of his enduring friendship with Tilda Swinton. Learn more about your ad choices. Visit podcastchoices.com/adchoices
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare